Page 14 - Contract Development News Today

Globally operating CDMO committed to strengthening Germany as a research and production location  Association grants Vetter extraordinary membershipvfa recognizes the importance of pharmaceutical service providers in drug development and productionVetter serves on key vfa committeesRAVENSBURG, Germany, January...

/PRNewswire/ -- Future Market Insights (FMI) latest industry analysis shows that the Global Advanced Therapeutics Pharmaceutical Outsourcing Market was valued...

LIC increased stake in Navin Fluorine International by 0.24% through open market. LIC bought 1.21 lakh shares of Navin Fluorine International on January 08 at an average price of ₹3,630.39 apiece.

Pluri, an established global leader in the development and manufacturing of cell-based therapeutics, launches new revenue-generating Contract Development and…

Dublin, Jan. 08, 2024 (GLOBE NEWSWIRE) -- The

<h4><i>The new four-story 20,000 m² facility will feature mammalian cell culture, messenger RNA and cell therapy services and be operational in 2026</i></h4><p/>SEATTLE, USA - News Direct - 04 January 2024 - <a href="https://www.agcbio.com/"><b>AGC</b> Biologics</a>, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), today announced plans to construct a new manufacturing facility at AGC ...

The report states that the burgeoning middle class in India is playing a pivotal role in catalysing a significant surge in healthcare expenditure 

AGC Biologics Announces Plans for New Manufacturing Site in Yokohama Japan

SEATTLE, USA - News Direct - 04 January 2024 - AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO),

WuXi Vaccines, a leading global Contract Development and Manufacturing Organisation (CDMO) specialising in vaccines, has been awarded the title of 'Best Vaccine CMO of the Year' for the second consecutive year at the 2023 Asia-Pacific Vaccine Excellence Awards (AVEA). Click to read more...